Work

Supplementary Figure 3 from Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling

Year: 2023
Type: supplementary-materials
Abstract: CSF1R-driven SHP2-dependent MAPK signaling in GDM-1 cells and SHP2 dependency of the viability in M-CSF-stimulated monocytes in the T cell co-culture assay, and the in vivo combination benefit in suppressing tumor associated macrophage by anti-PD-1 antibody and TNO155 in MC38 tumors.
Language: English
Open Access status: gold
OpenAlex ID: W4361962095
Cites:
Cited by:
Related to: 10